Pharma stock is 186% above 52-week-low, record date fixed for 2:1 bonus shares

The Board of Directors of the company said today in a stock exchange filing that “Pursuant to Regulation 42 of Listing Regulations, the Board of Directors have fixed Thursday, 22nd December, 2022 as the Record Date for the purpose of determining the Members who shall be entitled for allotment of bonus equity shares in the ratio of 2 :1 i.e. 2 (Two) new fully paid-up equity shares of Rs. 10/- each for every 1 (One) fully paid-up equity share of Rs. 10/- each held by the existing Members of the Company.”

The shares of Zim Laboratories Ltd closed today at ₹315.55 apiece, down by 1.45% from the previous close of ₹320.20. The stock recorded a total volume of 2,233 shares compared to the 20-Day average volume of 6,510 shares. In the last 1 year, the stock has fallen 4.76% and on a YTD basis, the stock has fallen 4.88% so far in 2022. The stock had touched a 52-week-high of ₹388.00 on (21/11/2022) and a 52-week-low of ₹110.15 on (22/12/2021), indicating that at the current market price the stock is trading 18.67% below the 1-year high and 186.47% above the 1 year low. 

For the quarter ended September 2022 or Q2FY23, the company reported a promoter shareholding of 33.26% and a public stake of 66.74%. For the financial year ended March or FY22, the company reported an ROE of 8.65%, a Return on Capital Employed of 12.52% and a Return on Assets (RoA) of 4.37%. For the quarter ended September or Q2FY23, the company recorded an EPS of ₹13.36, Price to Earning Ratio (PE) of 23.88, a book value per share of 115.33, and a PB ratio of 2.77, as per the data of StockEdge.